Growth of the Occlusion Devices Market Driven by Increased Investment and Innovation

The occlusion devices market has been on a strong upward trajectory in recent years, driven by various medical and technological factors. As healthcare continues to evolve, the demand for advanced occlusion devices is expected to increase steadily, supported by innovations and expanding applications across multiple medical specialties. Let's explore the current market size, key growth drivers, leading companies, and emerging trends shaping this sector.

Current Market Size and Projected Growth for Occlusion Devices
The occlusion devices market has experienced significant growth, rising to a value of $4.2 billion in 2025. It is forecasted to increase further to $4.6 billion by 2026, reflecting a compound annual growth rate (CAGR) of 9.6%. This expansion during the historical period is largely due to factors such as the rising incidence of cardiovascular diseases, advancements in interventional radiology techniques, an aging global population, the expansion of hospital infrastructure, and greater clinical adoption of embolization procedures.

Download a free sample of the occlusion devices market report:
https://thebusinessresearchcompany.com/sample_request?id=22768675&type=smp&name=Occlusion%20Devices%20Market%20Report%202026&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Nov_PR

Looking ahead, the market is expected to continue its robust growth, reaching an estimated $6.54 billion by 2030, with a CAGR of 9.2%. This positive outlook is driven by an increasing prevalence of neurological disorders, a shift toward minimally invasive surgeries, ongoing innovations in device technology, the growth of ambulatory care centers, and supportive reimbursement policies. Key trends anticipated to influence this growth include a growing preference for catheter-based therapies, an increased use of embolization procedures, expanding neurovascular interventions, and demand for highly precise occlusion devices.

Prominent Companies Shaping the Occlusion Devices Market
The occlusion devices landscape is dominated by several key players known for their innovation and market reach. These include Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Cook Group Incorporated, Merit Medical Systems Inc., Lepu Medical Technology Beijing Co. Ltd., MicroPort Scientific Corporation, Penumbra Inc., and Asahi Intecc Co. Ltd. Other significant companies include Angiodynamics Inc., LeMaitre Vascular Inc., Elixir Medical Corporation, Vascular Concepts Ltd., Occlutech, W L Gore & Associates Inc., LifeTech Scientific Corporation, Cardiovascular Systems Inc., Venus Medtech, CeloNova Biosciences, Cordis Corporation, Pfizer Inc., Sirtex Medical Limited, Nordion Canada Inc., AtriCure Inc., Phenox GmbH, and Balt Extrusion SAS.

View the full occlusion devices market report:
https://thebusinessresearchcompany.com/report/occlusion-devices-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Nov_PR

A notable recent development occurred in November 2023, when Amring Pharmaceuticals Inc., a US-based specialty pharma firm, acquired Laminar Inc. This acquisition combines Nordic Pharma's pharmaceutical expertise with Visant Medical's FDA-cleared hyaluronic acid derivative, LACRIFILL, a canalicular occlusive device designed to temporarily block tear drainage by occluding the canalicular system. Visant Medical specializes in manufacturing medical devices for dry eye treatment in the United States.

Innovations and Trends Driving the Occlusion Devices Industry
Leading companies in this market are focusing on developing next-generation occlusion devices that enhance the precision and efficiency of targeted embolization procedures. These advanced devices offer improved features, greater ease of use, and longer shelf lives compared to earlier models.

For example, in July 2025, Embolx, a US-based medical equipment manufacturer, introduced the Sniper G3 Balloon Occlusion Microcatheter. This third-generation device significantly improves targeted embolization by offering enhanced trackability, a simplified setup process that reduces preparation time to less than a minute, and doubles the shelf life to 24 months. The design of the Sniper G3 was heavily influenced by feedback from interventional radiologists, aiming to streamline clinical workflows and improve procedural outcomes. Available in all standard lengths, the device is ready for distribution worldwide and has established itself as a leading tool in embolization therapy.

Occlusion Devices Market Segmentation by Product, Application, and End User
This report segments the occlusion devices market into several key categories. By product type, the market includes occlusion removal devices, embolization devices, tubal occlusion devices, and support devices. The application segment covers neurology, cardiology, peripheral vascular diseases, urology, oncology, and gynecology. Regarding end users, the market is divided among hospitals, diagnostic and surgical centers, ambulatory care centers, and research laboratories and academic institutes.

Further subcategories provide more detail: Occlusion removal devices are subdivided into thrombectomy devices, catheter-based occlusion removal devices, aspiration systems, and mechanical clot retrieval systems. Embolization devices include coil, particle, balloon, gel, liquid, and stent-assisted embolization devices. Tubal occlusion devices feature Essure devices, hysteroscopic sterilization systems, fallopian tube clips, and tubal ligation devices. Support devices encompass occlusion catheters, guidewires for occlusion, supportive sheaths, and stent-grafts for occlusion support.

This segmentation provides a comprehensive view of the market's diverse product offerings and their applications across multiple medical fields.

Our 2026 market reports now feature expanded strategic intelligence through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, key technology and future trend analysis, along with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.